CAC China 2025 Tocopharm will join in CAC 2025 from March 17 to March 19 in Shanghai. The China International Agrochemical & Crop Protection Exhibition (CAC) is a yearly event that connects buyers and suppliers in the agrochemical industry. The exhibition is held at the National Exhibition and Convention Center in Shanghai, China.
READ MORE
New salicylic acid-based strategy could balance disease resistance with plant growth Researchers at the University of Georgia have identified a promising approach to addressing a longstanding challenge for plant geneticists: balancing disease resistance and growth in plants. The breakthrough could help protect plants from disease in the future while also promoting higher biomass yields to support sustainable food supplies for both humans and animals, production of biofuels and lumber, and more, according to the new study. The paper is published in The Plant Cell journal. "Combating pathogens has been a top challenge in agriculture," said C.J. Tsai, corresponding author of the study and a professor in UGA's Warnell School of Forestry and Natural Resources and Franklin College of Arts and Sciences. "Solutions that balance disease resistance and growth are much needed, especially with the ever-increasing disease pressure due to climate change."
READ MORE
Captisol-enabled Contrast Media with Reduced Renal Toxicity in Development This case study was sponsored by Ligand Pharmaceuticals The medical imaging market relies heavily on contrast media, injected into patients to increase the contrast of bodily structures in images and improve diagnostic examinations. In radiographic imaging procedures, iodinated contrast agents can greatly enhance X-rays or computed tomography (CT) images. But many contrast agents carry with them the risk of nephrotoxicity, or renal toxicity, for patients with significant and lingering kidney issues. This risk can lead to the need for renal replacement therapy, or result in rehospitalization and even death. Currently many scientists are searching for ways to develop a more kidney-safe contrast agent for this subgroup of patients. Ligand’s Captisol-enabled iohexol is poised to offer a new opportunity for the diagnostic imaging market.
READ MORE
